MUTYH mutations do not cause HNPCC or late onset familial colorectal cancer

Hereditary Cancer in Clinical Practice

Volumn 4, Issue 2, 2006, Pages 90-93

  Stormorken, Astrid ^a   Heintz, Karen Marie ^a   Andresen, Per Arne ^a   Hovig, Eivind ^a   Møller, Pål ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Familial adenomatous polyposis coli; Hereditary non polyposis colorectal cancer; Late onset familial colorectal cancer; MUTYH mutations

Indexed keywords

DNA GLYCOSYLASE MUTY;

ADENOMATOSIS; ADULT; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; EXCISION REPAIR; EXON; FAMILIAL CANCER; FAMILIAL POLYPOSIS; FEMALE; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR;

EID: 33745713730     PISSN: 17312302     EISSN: None     Source Type: Journal    
DOI: 10.1186/1897-4287-4-2-90     Document Type: Article

References (24)

1. Jones S, Emmerson P, Maynard J, Best JM, Jordan S, Williams GT, Sampson JR and Cheadle JP. Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C→T:A mutations. Hum Mol Genet 2002; 11: 2961-2967.
2. Ames BN and Gold LS. Endogenous mutagens and the causes of aging and cancer. Mutat Res 1991; 250: 3-16.
3. Halford SER, Rowan AJ, Lipton L, Sieber OM, Pack K, Thomas HJW, Hodgson SV, Bodmer WF and Tomlinson PM. Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers. Am J Pathol 2003; 162: 1545-1548.
4. Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, Hodes AK, Rhodri Davies D, David SS, Sampson JR and Cheadle JP. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumours. Nat Genet 2002; 30: 227-232.
5. Gismondi V, Meta M, Bonelli L, Radice P, Sala P, Bertario L, Viel A, Fornasarig M, Arrigoni A, Gentile M, Ponz de Leon M, Anselmi L, Mareni C, Bruzzi P and Varesco L. Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas. Int J Cancer 2004; 109: 680-684.
6. Enholm S, Hienonen T, Suomalainen A, Lipton L, Tomlinson I, Körjä V, Eskelinen M, Mecklin J-P, Karhu A, Järvinen HJ and Aaltonen LA. Proportion and phenotype of MYH-associated colorectal neoplasia in a population-based series of Finnish colorectal cancer patients. Am J Pathol 2003; 163: 827-832.
7. Fleischmann C, Peto J, Cheadle J, Shah B, Sampson J and Houlston RS. Comprehensive analysis of the contribution of germline MYH variation to early-onset colorectal cancer. Int J Cancer 2004; 109: 554-558.
8. Kambara T, Whitehall VL, Spring KJ, Barker MA, Arnold S, Wynter CV, Matsubara N, Tanaka N, Young JP, Leggett BA and Jass JR. Role of inherited defects of MYH in the development of sporadic colorectal cancer. Genes Chromosomes Cancer 2004; 40: 1-9.
9. Kairupan CF, Meldrum CJ, Crooks R, Milward EA, Spigelman AD, Burgess B, Groombridge C, Kirk J, Tucker K, Ward R, Williams R and Scott RJ. Mutation analysis of the MYH gene in an Australian series of colorectal polyposis patients with or without germline APC mutations. Int J Cancer 2005; 116: 73-77.
10. Gu Y, Parker A, Wilson TM, Bai H, Chang D and Lu A. Human MutY Homolog, a DNA glycosylase involved in base excision repair, physically and functionally interacts with mismatch repair proteins human MutS homolog 2/Human MutS homolog 6. J Biol Chem 2002; 277: 11135-11142.
11. Bai H, Jones S, Guan X, Wilson TM, Sampson JR, Cheadle JP and Lu A. Functional characterization of two human MutY homolog (hMYH) missense mutations (R227W and V232F) that lie within the putative hMSH6 binding domain and are associated with hMYH polyposis. Nucleic Acids Res 2005; 33: 597-604.
12. Ashton KA, Meldrum CF, McPhillips ML, Kairupan CF and Scott RJ. Frequency of the common MYH mutations (G382D and Y165C) in MMR mutation positive and negative HNPCC patients. Hereditary cancer in clinical practice 2005; 3: 65-70.
13. Croitoru ME, Cleary SP, di Nicola N, Manno M, Selander T, Aronson M, Redston M, Cotterchio M, Knight J, Gryfe R and Gallinger S. Association between biallelic and monoallelic germline MYH mutations and colorectal cancer risk. J Natl Cancer Inst 2004; 96: 1631-1634.
14. Stormorken AT, Müller W, Lemkemeyer B, Apold J, Wijnen J, Fodde R, Möslein G and Møller P. Prediction of the outcome of genetic testing in HNPCC kindreds using the revised Amsterdam criteria and immunohistochemistry. Fam Cancer 2001; 1: 169-173.
15. Stormorken A, Bowitz-Lothe IM, Norén T, Kure E, Aase S, Wijnen J, Apold J Heimdal K and Møller P. Immunohistochemistry identifies carriers of mismatch repair gene defects causing HNPCC. J Clin Oncol 2005; 23: 4705-12.
16. Møller P. Genetic cancer: a challenge and a possible strategy. J Cancer Care 1993; 2: 94-99.
17. Vasen FA, Watson P, Mecklin J-P, Lynch HT and the ICG-HNPCC. New clinical criteria for hereditary non-polyposis colorectal caner (HNPCC, Lynch syndrome) proposed by the international collaborative group on HNPCC. Gastroenterol 1999; 116: 1453-1456.
18. Norwegian Gastrointestinal Cancer Group (NGICG). Norwegian, http://ngicg.no
19. Thibodeau SN, French AJ, Roche PC, Cunningham JM, Tester DJ, Lindor NM, Möslein G, Baker SM, Liskay M, Burgart LJ, Honchel R and Hailing KC. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1996; 56: 4836-4840.
20. de Leeuw WJF, Dierssen JW, Vasen HFA, Wijnen JT, Kenter GG, Meijers-Heijboer H, Brocker-Vriends A, Stormorken A, Møller P, Menko F, Cornelisse and Morreau H. Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumors from HNPCC patients. J Pathol 2000; 192: 328-35.
21. Wijnen J, van der Klift H, Vasen, Meera Khan P, Menko F, Tops C, Meijers-Heijboer A, Lindhout D, Møller P and Fodde R. MSH2 genomic deletions are a frequent cause of HNPCC. Nat Genet 1998; 20: 326-328.
22. Eliason K, Hendrickson BC, Judkins T, Norton M, Leclair B, Lyon E, Ward B, Noll W and Scholl T. The potential for increased clinical sensitivity in genetic testing for polyposis colorectal cancer through the analysis of MYH mutations in North American patients. J Med Genet 2005; 42: 95-96.
23. Farrington SM, Tenesa A, Barnetson R, Wiltshire A, Prendergast J, Porteous M, Campbell H and Dunlop MG. Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet 2005; 77: 112-11 9.
24. Nielsen M, Franken PF, Reinards TH, Weiss MM, Wagner A, van der Klift H, Kloosterman S, Houwing-Duistermaat JJ, Aalfs CM, Ausems MG, Brocker-Vriends AH, Gomez Garcia EB, Hoogerbrugge N, Menko FH, Sijmons RH, Verhoef S, Kuipers EJ, Morreau H, Breuning MH, Tops CM, Wijnen JT, Vasen HF, Fodde R and Hes FJ. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet 2005; 42(9): e54.